The drug that buoyed expectations for a coronavirus treatment and drew international attention for Gilead Sciences, remdesivir, started as a reject, an also-ran in the search for antiviral drugs. Its…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *